Computational simulation of patients with respiratory disease - what is it good for? Declan Bates Professor of Bioengineering Co-Director WISB /
|
|
- Rodney Griffin
- 5 years ago
- Views:
Transcription
1 Computational simulation of patients with respiratory disease - what is it good for? Declan Bates Professor of Bioengineering Co-Director WISB / SynBio CDT / ICSM School of Engineering University of Warwick
2 Optimising paediatric / neonatal critical care Talk Overview Introduction to Systems Medicine Simulators as systems engineering tools for therapeutic optimisation Protective ventilation in acute respiratory distress syndrome (ARDS) Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD)
3 Introduction to Systems Medicine Systems Medicine: Fuses disciplines underlying medicine (biology, physiology, pathology, pharmacology, epidemiology and therapeutics) with computer science, mathematics, and engineering Exploits the development of computational models that map the (mal)functioning of the human body, its processes and interactions across multiple levels of structural and functional organisation - from molecular reactions, to cell-cell interactions in tissues, to the physiology of organs and organ systems
4 Introduction to Systems Medicine Key drivers: Data avalanches (at all scales) Dramatic increases in computational power (and reductions in cost) Patient demand for more personalised treatment strategies Faltering industrial drug development pipeline too slow, too expensive, not enough new targets, too many failed clinical trials Reduction, refinement & replacement of animal models Attention of regulatory agencies
5 USING THIS CONTENT... II PUBLISHER... II TABLE OF CONTENT... III PREAMBLE... V THE NEED FOR A NEW CONCEPT IN MEDICINE... V ABBREVIATIONS... 2 WHY IS Strong SYSTEMS MEDICINE interest NEEDED?... from funding agencies: 3 A PARADIGM SHIFT TOWARD IMPLEMENTING SYSTEMS MEDICINE... 5 BACKGROUND... 6 A NEW PARADIGM IN HEALTHCARE... 6 WHY THIS ROADMAP?... 7 THE AIMS OF THE ROADMAP ARE TO:... 7 TO DEFINE OR NOT DEFINE?... 7 DEFINITION OF SYSTEMS MEDICINE... 7 STATE OF THE ART... 8 THE CHALLENGE OF DISEASE COMPLEXITY... 8 RELEVANCE OF SYSTEMS MEDICINE TO CLINICIANS... 9 HARNESSING COMPUTATIONAL, STATISTICAL AND MATHEMATICAL TOOLS TO ANALYSE AND INTERPRET BIOMEDICAL DATA... 9 RECOMMENDATION IMPLEMENTATION STRATEGY FOR SYSTEMS MEDICINE THE TEN KEY AREAS FOR A SUCCESSFUL IMPLEMENTATION OF SYSTEMS MEDICINE IMPROVING THE DESIGN OF CLINICAL TRIALS METHODOLOGY AND TECHNOLOGY DEVELOPMENT INCLUDING MODELLING DATA GENERATION TECHNOLOGICAL INFRASTRUCTURE PATIENT STRATIFICATION FOR A MORE PERSONALIZED MEDICINE WORKING WITH INDUSTRY ETHICAL AND REGULATORY ISSUES MULTIDISCIPLINARY TRAINING STAKEHOLDER ENGAGEMENT: COMMUNITY BUILDING, NETWORKING AND DISSEMINATING THE SYSTEMS MEDICINE CONCEPT INTEGRATION OF NATIONAL EFFORTS IN SYSTEMS MEDICINE AND WITHIN THE EU CORE PRIORITY ACTIONS Introduction to Systems Medicine THE CAS
6 Introduction to Systems Medicine Strong interest from industry: Virtual patients allow novel treatment strategies to be investigated across different types of patients in a safe, cost-effective and reproducible in silico environment Entelos: asthma, obesity, Type 1 and Type 2 diabetes, rheumatoid arthritis, cholesterol metabolism, cardiovascular, skin sensitization, etc. Bio-Simulation Market to exceed $2B by 2020 US FDA starting to explore use of simulators for certification
7 Simulators as systems engineering tools for therapeutic optimisation The problem: Treatment strategies for critical lung disease essentially based on mechanical ventilation to restore physiological flows and tissue oxygenation Despite numerous studies: Mortality rate of ICU patients has not changed significantly over the past 30 years Still at about 35% Little progress in shortening the period of time spent on the ventilator
8 Simulators as systems engineering tools for therapeutic optimisation The problem: Very difficult to conduct clinical research on critically ill patients many practical / ethical issues Animal models not fit for purpose Limited understanding of the human/machine interface Difficult to look inside the lung Clinical trials massively expensive and difficult
9 A computational simulator that includes representations of multiple, interacting organ systems (cardiac, vascular, pulmonary, etc) Simulators as systems engineering tools for therapeutic optimisation Multiple, independent, viscoelastic, gasexchanging alveolar compartments Interdependent blood-gas solubilities Pulsatile blood flow generated by a multichamber heart Heterogeneous distributions of
10 Verification & Validation: Statistical clinical approaches + formal engineering methods Essential to convince clinicians and regulatory authorities Simulators as systems engineering tools for therapeutic optimisation
11 Optimising settings ventilator Optimal settings are different for different disease states Protective ventilation in acute respiratory distress syndrome (ARDS) Lower risk of lung injury Sweet Spot Combinatorial complexity of the problem defeats clinical intuition Better gas exchange A. Das, P.P. Menon, J. Hardman and D.G. Bates, Optimization of Ventilation Settings for Pulmonary Disease States, IEEE Transactions on Biomedical Engineering, A. Das, O. Cole, M. Chikhani, W. Wang, J.G. Hardman and D.G. Bates, "Evaluation of lung recruitment maneuvers in Acute Respiratory Distress Syndrome using computer simulation", Critical Care, M. Chikhani, A. Das, M. Haque, W. Wang, D.G. Bates, and J.G. Hardman, "High PEEP in ARDS: evaluating the
12 Protective ventilation in acute respiratory distress syndrome (ARDS) Optimising ventilator settings: PEEP: pressure in the lungs at the end of expiration ΔP: plateau
13 Optimising ventilator settings: Protective ventilation in acute respiratory distress syndrome (ARDS) PEEP: pressure in the lungs at the end of expiration ΔP: plateau
14 Optimising ventilator settings: Protective ventilation in acute respiratory distress syndrome (ARDS) A B C D E F G H I J K L A. Das, L. Camporota, J.G. Hardman and D.G. Bates, "What links ventilator driving pressure with survival in the acute respiratory distress syndrome?", under review, Critical Care Medicine, 2018.
15 Optimising ventilator settings: Protective ventilation in acute respiratory distress syndrome (ARDS) A B C D E F G H I J K L M N O P Q R S T U A. Das, L. Camporota, J.G. Hardman and D.G. Bates, "What links ventilator driving pressure with survival in the acute respiratory distress syndrome?", under review, Critical Care Medicine, 2018.
16 COPD: Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) A leading cause of mortality and disability Predicted to be the 3rd greatest cause of death worldwide by 2020 Causes: smoking (mainly), long-term exposure to lung irritants such as industrial dust and chemical fumes, preterm birth, inherited factors A progressive disease, associated with increasing frequency and severity of exacerbations
17 Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) What we want to match: Measured outputs + V/Q curves Healthy lung Ventilation and Perfusion must be matched at the alveolar capillary level ideal V/Q ratio is 1
18 Deadspac Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) What we want to match: Measured outputs + V/Q curves Shunt Diseased lung Disease increases number of alveoli with low and high V/Q ratios (shunt and dead space, respectively)
19 Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) Automated matching to patient V/Q curves: compartments 50 compartments 100 Need sufficient model complexity to represent individual patients W. Wang, A. Das, T. Ali, O. Cole, M. Chikhani, M. Haque, J.G. Hardman and D.G. Bates, "Can computer simulators accurately represent the pathophysiology of individual COPD patients?", Intensive Care Medicine
20 Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) The problem: Pulmonary Hypertension (PH) One of the most serious complications of COPD A progressive and debilitating condition associated with a sustained increase in: mean pulmonary artery pressure (mpap) pulmonary vascular resistance (PVR) Joint work with:
21 Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) The problem: Various drugs with different modes of action investigated as potential PH-specific therapies in clinical studies Generally aim for a dilation or relaxation of the pulmonary arterial vessels, thus reducing the arterial pressure Sildenafil PDE 5 inhibitor Riociguat - soluble guanylate synthase (sgc) stimulator
22 Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) In recent clinical trials: Systemic (oral) administration of Riociguat resulted in: Improved 6-minute walk distance Significant reductions in mpap and PVR But Deterioration of V/Q matching and oxygenation Why?
23 Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) Hypoxic vasoconstriction Natural physiological response that reduces blood flow to hypoxic (unoxygenated) regions of the lung Systemic (oral) administration of of Riociguat inhibits hypoxic vasoconstriction by increasing blood flow throughout the whole
24 Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) Hypoxic vasoconstriction Natural physiological response that reduces blood flow to hypoxic (unoxygenated) regions of the lung Systemic (oral) administration of of Riociguat inhibits hypoxic vasoconstriction by increasing blood flow throughout the whole PaO2 reduced by 13% PaCO2 increased by 4% Deadspace Shunt
25 Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) What if the drug was administered via inhalation? Here Now the drug should only be deposited in those regions of the lung that are oxygenated Could achieve same level of PVR reduction without worsening oxygenation? Not Here
26 Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) Model matching: PVR reduction due to drug:
27 Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) Assuming the same PVR reduction, we modelled systemic drug application and administration via dry powder inhalation (DPI) DPI is associated with a deep breath and hence a transitory reduction in airway resistance:
28 Even better under exercise Treating pulmonary hypertension in chronic obstructive pulmonary disease (COPD) Results PaO2 (mmhg) PaO2 (mmhg) PaO2 (mmhg) Patient 1 Patient 2 Patient 3 Systemic Application PaCO2 (mmhg) PaCO2 (mmhg) Inhalation with Deep Breath at Rest Inhalation with Deep Breath under Exercise PaCO2 (mmhg) W. Wang, A. Das, W. Schmitt, J.G. Hardman, G. Weimann and D.G. Bates, "An inhaled sgc modulator can lower G +20.2% H PH in COPD patients without deteriorating oxygenation", 50 in press, CPT: Pharmacometrics -11.2% & Systems 120 Hg) A C E +5.1% +0.8% +2.4% Exercise -29.4% -24.3% -18.6% +1.6% +1.5% +1.7% mhg) B D -3.3% -2.0% -2.5% Exercise Inhalation with Normal Breath F +9.9% +8.8% +9.0% Deterioration in oxygenation after systematic application matches that seen in clinical trials +0.1% +0.0% -0.7% No deterioration in oxygenation when drug administered via DPI
29 Optimising paediatric / neonatal critical care Two new collaborations with paediatric intensive care clinicians: Simulator adapted to paediatric physiology: S. Saffaran, A. Das, J.G. Hardman, N. Yehya, and D.G. Bates, "Development and Validation of a Computational Simulator for Pediatric ARDS Patients", in proceedings of the 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, JeJu Island, S. Korea, 2017.
30 present the distribution of patients driving pressures and mechanical power. Tables: Optimising paediatric / neonatal critical care Table 1. Patient characteristics and mechanical ventilator settings for each individual patient, and as mean and standard deviations (SD) across the cohort. Patient Age Weight FiO 2 RR V T PEEP PF OI PaO 2 P E CO 2 PaCO 2 PIP mpaw (y) (kg) (bpm) (ml/kg) (cmh 2O) (mmhg) (cmh 2O) # # # # # # # # # # # # # # # # # # # # # # # # # # # # # # Mean SD
31 Optimising paediatric / neonatal critical care Lowering tidal volumes during mechanical ventilation decreases mortality in adult ARDS patients No randomized trials to determine appropriate tidal volumes in paediatric ARDS Available observational studies are inconclusive Average reductions in tidal volume of 21% could be safely achieved in
32 Acknowledgements Synthetic Biology: Jack Bowyer, Nuno Paulino, Mathias Foo, Alex Darlington, Iulia Gherman Wilson Wong (Boston) Victoria Hsiao (Caltech / Aymeris) Katherine Denby (York) Systems Medicine: Anup Das, Sina Saffaran, Wenfei Wang Jonathan Hardman, Don Sharkey (Nottingham), Nadir Yehya (CHOPS) Luigi Camporota (KCL) Walter Schmitt (Bayer)
1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation.
Chapter 1: Principles of Mechanical Ventilation TRUE/FALSE 1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation. F
More informationAPRV Ventilation Mode
APRV Ventilation Mode Airway Pressure Release Ventilation A Type of CPAP Continuous Positive Airway Pressure (CPAP) with an intermittent release phase. Patient cycles between two levels of CPAP higher
More informationThe new ARDS definitions: what does it mean?
The new ARDS definitions: what does it mean? Richard Beale 7 th September 2012 METHODS ESICM convened an international panel of experts, with representation of ATS and SCCM The objectives were to update
More informationQuickLung Breather Patient Settings
The QuickLung Breather is capable of simulating a spontaneously breathing patient in a variety of modes and patterns. In response to customer requests, we have compiled five common respiratory cases below.
More informationCardiorespiratory Interactions:
Cardiorespiratory Interactions: The Heart - Lung Connection Jon N. Meliones, MD, MS, FCCM Professor of Pediatrics Duke University Medical Director PCVICU Optimizing CRI Cardiorespiratory Economics O2:
More informationOmar Sami. Mustafa Khader. Yanal Shafaqouj
8 Omar Sami Mustafa Khader Yanal Shafaqouj Let us retrieve our discussion about the ventilation-perfusion ratio (V/Q). - When (V/Q) is Zero this means that no ventilation is taking place, V is Zero; bronchial
More informationCritical Care Monitoring. Assessing the Adequacy of Tissue Oxygenation. Tissue Oxygenation - Step 1. Tissue Oxygenation
Critical Care Monitoring 1 Assessing the Adequacy of Tissue oxygenation is the end-product of many complex steps 2 - Step 1 Oxygen must be made available to alveoli 3 1 - Step 2 Oxygen must cross the alveolarcapillary
More informationPAEDIATRIC RESPIRATORY FAILURE. Tang Swee Fong Department of Paediatrics University Kebangsaan Malaysia Medical Centre
PAEDIATRIC RESPIRATORY FAILURE Tang Swee Fong Department of Paediatrics University Kebangsaan Malaysia Medical Centre Outline of lecture Bronchiolitis Bronchopulmonary dysplasia Asthma ARDS Bronchiolitis
More informationMechanical Ventilation. Assessing the Adequacy of Tissue Oxygenation. Tissue Oxygenation - Step 1. Tissue Oxygenation
1 Mechanical Ventilation Assessing the Adequacy of 2 Tissue oxygenation is the end-product of many complex steps - Step 1 3 Oxygen must be made available to alveoli 1 - Step 2 4 Oxygen must cross the alveolarcapillary
More informationVeno-Venous ECMO Support. Chris Cropsey, MD Sept. 21, 2015
Veno-Venous ECMO Support Chris Cropsey, MD Sept. 21, 2015 Objectives List indications and contraindications for ECMO Describe hemodynamics and oxygenation on ECMO Discuss evidence for ECMO outcomes Identify
More informationACUTE RESPIRATORY DISTRESS SYNDROME
ACUTE RESPIRATORY DISTRESS SYNDROME Angel Coz MD, FCCP, DCE Assistant Professor of Medicine UCSF Fresno November 4, 2017 No disclosures OBJECTIVES Identify current trends and risk factors of ARDS Describe
More informationOxygenation Failure. Increase FiO2. Titrate end-expiratory pressure. Adjust duty cycle to increase MAP. Patient Positioning. Inhaled Vasodilators
Oxygenation Failure Increase FiO2 Titrate end-expiratory pressure Adjust duty cycle to increase MAP Patient Positioning Inhaled Vasodilators Extracorporeal Circulation ARDS Radiology Increasing Intensity
More informationINTRODUCTION The effect of CPAP works on lung mechanics to improve oxygenation (PaO 2
2 Effects of CPAP INTRODUCTION The effect of CPAP works on lung mechanics to improve oxygenation (PaO 2 ). The effect on CO 2 is only secondary to the primary process of improvement in lung volume and
More informationTracking lung recruitment and regional tidal volume at the bedside. Antonio Pesenti
Tracking lung recruitment and regional tidal volume at the bedside Antonio Pesenti Conflicts of Interest Maquet: Received research support and consultation fees Drager: Received research support and consultation
More informationApplication of Lung Protective Ventilation MUST Begin Immediately After Intubation
Conflict of Interest Disclosure Robert M Kacmarek Managing Severe Hypoxemia!" 9-28-17 FOCUS Bob Kacmarek PhD, RRT Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts I disclose
More informationLecture Notes. Chapter 2: Introduction to Respiratory Failure
Lecture Notes Chapter 2: Introduction to Respiratory Failure Objectives Define respiratory failure, ventilatory failure, and oxygenation failure List the causes of respiratory failure Describe the effects
More informationIRDS, Infantile Respiratory Distress Syndrome
IRDS, Infantile Respiratory Distress Syndrome - RDS is the leading cause of death in the newborns, and the most common cause of death first 15 years of life (excluding the malformed babies). - RDS is the
More information9/5/2018. Conflicts of Interests. Pediatric Acute Respiratory Distress Syndrome. Objectives ARDS ARDS. Definitions. None
Pediatric Acute Respiratory Distress Syndrome Conflicts of Interests Diane C Lipscomb, MD Director Inpatient Pediatric Medical Director Mercy Springfield Associate Clerkship Clinical Director University
More informationRespiratory insufficiency in bariatric patients
Respiratory insufficiency in bariatric patients Special considerations or just more of the same? Weaning and rehabilation conference 6th November 2015 Definition of obesity Underweight BMI< 18 Normal weight
More informationACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv.8.18.18 ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) SUDDEN PROGRESSIVE FORM OF ACUTE RESPIRATORY FAILURE ALVEOLAR CAPILLARY MEMBRANE BECOMES DAMAGED AND MORE
More informationChronic Obstructive Pulmonary Disease
136 PHYSIOLOGY CASES AND PROBLEMS Case 24 Chronic Obstructive Pulmonary Disease Bernice Betweiler is a 73-year-old retired seamstress who has never been married. She worked in the alterations department
More informationOXYGENATION AND ACID- BASE EVALUATION. Chapter 1
OXYGENATION AND ACID- BASE EVALUATION Chapter 1 MECHANICAL VENTILATION Used when patients are unable to sustain the level of ventilation necessary to maintain the gas exchange functions Artificial support
More informationCapnography. Capnography. Oxygenation. Pulmonary Physiology 4/15/2018. non invasive monitor for ventilation. Edward C. Adlesic, DMD.
Capnography Edward C. Adlesic, DMD University of Pittsburgh School of Dental Medicine 2018 North Carolina Program Capnography non invasive monitor for ventilation measures end tidal CO2 early detection
More informationPulmonary Pathophysiology
Pulmonary Pathophysiology 1 Reduction of Pulmonary Function 1. Inadequate blood flow to the lungs hypoperfusion 2. Inadequate air flow to the alveoli - hypoventilation 2 Signs and Symptoms of Pulmonary
More informationCapnography Connections Guide
Capnography Connections Guide Patient Monitoring Contents I Section 1: Capnography Introduction...1 I Section 2: Capnography & PCA...3 I Section 3: Capnography & Critical Care...7 I Section 4: Capnography
More informationCapnography 101. James A Temple BA, NRP, CCP
Capnography 101 James A Temple BA, NRP, CCP Expected Outcomes 1. Gain a working knowledge of the physiology and science behind End-Tidal CO2. 2.Relate End-Tidal CO2 to ventilation, perfusion, and metabolism.
More informationNitric Resource Manual
Nitric Resource Manual OBJECTIVES Describe the biologic basis for inhaled nitric oxide therapy Describe the indications for inhaled nitric oxide therapy Describe the potential hazards, side effects and
More informationBy Mark Bachand, RRT-NPS, RPFT. I have no actual or potential conflict of interest in relation to this presentation.
By Mark Bachand, RRT-NPS, RPFT I have no actual or potential conflict of interest in relation to this presentation. Objectives Review state protocols regarding CPAP use. Touch on the different modes that
More information1
1 2 3 RIFAI 5 6 Dublin cohort, retrospective review. Milrinone was commenced at an initial dose of 0.50 μg/kg/minute up to 0.75 μg/kg/minute and was continued depending on clinical response. No loading
More informationKeep. with life MEDICATION TECHNOLOGY SERVICES INSPIRED BY YOUR NEEDS
Keep with life MEDICATION TECHNOLOGY SERVICES INSPIRED BY YOUR NEEDS 2 KINOX MEDICATION KINOX, inhaled nitric oxide, is a selective pulmonary vasodilator developed by Air Liquide Healthcare and characterized
More informationLandmark articles on ventilation
Landmark articles on ventilation Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity ARDS AECC DEFINITION-1994 ALI Acute onset Bilateral chest infiltrates PCWP
More informationRecognizing and Correcting Patient-Ventilator Dysynchrony
2019 KRCS Annual State Education Seminar Recognizing and Correcting Patient-Ventilator Dysynchrony Eric Kriner BS,RRT Pulmonary Critical Care Clinical Specialist MedStar Washington Hospital Center Washington,
More informationStart of Phase IIIb Study with Bayer s Riociguat in PAH Patients Who Demonstrate an Insufficient Response to PDE-5 Inhibitors
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Pulmonary Arterial Hypertension (PAH): Start of Phase IIIb Study with Bayer
More informationACUTE RESPIRATORY DISTRESS SYNDROME CHALLENGES FOR TRANSLATIONAL RESEARCH AND OPPORTUNITIES FOR PRECISION MEDICINE
ACUTE RESPIRATORY DISTRESS SYNDROME CHALLENGES FOR TRANSLATIONAL RESEARCH AND OPPORTUNITIES FOR PRECISION MEDICINE Acute respiratory distress syndrome: challenges for translational research and opportunities
More informationSCVMC RESPIRATORY CARE PROCEDURE
Page 1 of 7 New: 12/08 R: 4/11 R NC: 7/11, 7/12 B7180-63 Definitions: Inhaled nitric oxide (i) is a medical gas with selective pulmonary vasodilator properties. Vaso-reactivity is the evidence of acute
More informationLab 4: Respiratory Physiology and Pathophysiology
Lab 4: Respiratory Physiology and Pathophysiology This exercise is completed as an in class activity and including the time for the PhysioEx 9.0 demonstration this activity requires ~ 1 hour to complete
More informationBreathing life into new therapies: Updates on treatment for severe respiratory failure. Whitney Gannon, MSN ACNP-BC
Breathing life into new therapies: Updates on treatment for severe respiratory failure Whitney Gannon, MSN ACNP-BC Overview Definition of ARDS Clinical signs and symptoms Causes Pathophysiology Management
More informationPediatric Acute Respiratory Distress Syndrome (PARDS): Do we have consensus? Doug Willson, MD Children s Hospital of Richmond at VCU April 20, 2015
Pediatric Acute Respiratory Distress Syndrome (PARDS): Do we have consensus? Doug Willson, MD Children s Hospital of Richmond at VCU April 20, 2015 Conflicts to Disclose! I am a consultant for Discovery
More informationBiomedical engineer s guide to the clinical aspects of intensive care mechanical ventilation
https://doi.org/10.1186/s12938-018-0599-9 BioMedical Engineering OnLine REVIEW Open Access Biomedical engineer s guide to the clinical aspects of intensive care mechanical ventilation Vincent J. Major
More informationΕπεμβατικές στρατηγικές στην πνευμονική υπέρταση
Επεμβατικές στρατηγικές στην πνευμονική υπέρταση Παναγιώτης Καρυοφύλλης Καρδιολόγος Ωνάσειο Καρδιοχειρουργικό Κέντρο Mortality in PAH 2015 ESC/ERS Guidelines. Treatment algorithm Since BAS is performed
More informationThe use of proning in the management of Acute Respiratory Distress Syndrome
Case 3 The use of proning in the management of Acute Respiratory Distress Syndrome Clinical Problem This expanded case summary has been chosen to explore the rationale and evidence behind the use of proning
More informationLearning Objectives. 1. Indications versus contra-indications 2. CPAP versus NiVS 3. Clinical evidence
Learning Objectives 1. Indications versus contra-indications 2. CPAP versus NiVS 3. Clinical evidence Pre-hospital Non-invasive vventilatory support Marc Gillis, MD Imelda Bonheiden Our goal out there
More informationECMO Experience from ECMO-ICU, Karolinska
ECMO Experience from ECMO-ICU, Karolinska X Curso de Ventilacion Mecanica en Anestesia, Cuidados Criticos y Transplantes Madrid 2012 International numbers Totally since 1989; 46500 patients as of July
More informationARDS: The Evidence. Topics. New definition Breaths: Little or Big? Wet or Dry? Moving or Still? Upside down or Right side up?
ARDS: The Evidence Todd M Bull MD Professor of Medicine Division of Pulmonary Sciences and Critical Care Division of Cardiology Director Pulmonary Vascular Disease Center Director Center for Lungs and
More informationARDS: an update 6 th March A. Hakeem Al Hashim, MD, FRCP SQUH
ARDS: an update 6 th March 2017 A. Hakeem Al Hashim, MD, FRCP SQUH 30M, previously healthy Hx: 1 week dry cough Gradually worsening SOB No travel Hx Case BP 130/70, HR 100/min ph 7.29 pco2 35 po2 50 HCO3
More informationDr. Yasser Fathi M.B.B.S, M.Sc, M.D. Anesthesia Consultant, Head of ICU King Saud Hospital, Unaizah
BY Dr. Yasser Fathi M.B.B.S, M.Sc, M.D Anesthesia Consultant, Head of ICU King Saud Hospital, Unaizah Objectives For Discussion Respiratory Physiology Pulmonary Graphics BIPAP Graphics Trouble Shootings
More information7/4/2015. diffuse lung injury resulting in noncardiogenic pulmonary edema due to increase in capillary permeability
Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Objectives Identify the 5 criteria for the diagnosis of ARDS. Discuss the common etiologies
More informationRESPIRATORY FAILURE. Michael Kelly, MD Division of Pediatric Critical Care Dept. of Pediatrics
RESPIRATORY FAILURE Michael Kelly, MD Division of Pediatric Critical Care Dept. of Pediatrics What talk is he giving? DO2= CO * CaO2 CO = HR * SV CaO2 = (Hgb* SaO2 * 1.34) + (PaO2 * 0.003) Sound familiar??
More informationGuideline for the Use of inhaled Nitric Oxide (NO) Catarina Silvestre Prof. Harish Vyas
Inhaled Nitric Oxide Title of Guideline Guideline for the Use of inhaled Nitric Oxide (NO) 1a 2a 2b Contact Name and Job Title (author) Directorate & Speciality Date of submission October 2015 Date when
More informationSurfactant Administration
Approved by: Surfactant Administration Gail Cameron Senior Director Operations, Maternal, Neonatal & Child Health Programs Dr. Paul Byrne Medical Director, Neonatology Neonatal Policy & Procedures Manual
More informationManagement of Respiratory Disease in the Term Infant
Management of Respiratory Disease in the Term Infant David Tingay 1. Neonatal Research, Murdoch Children s Research Institute, Melbourne 2. Neonatology, Royal Children s Hospital 3. Dept of Paediatrics,
More informationAirway pressure release ventilation (APRV) in PICU: Current evidence. Chor Yek Kee Sarawak General Hospital
Airway pressure release ventilation (APRV) in PICU: Current evidence Chor Yek Kee Sarawak General Hospital Outline Brief introduction of APRV History of APRV Common confusion in APRV Features of APRV and
More informationThe Art and Science of Weaning from Mechanical Ventilation
The Art and Science of Weaning from Mechanical Ventilation Shekhar T. Venkataraman M.D. Professor Departments of Critical Care Medicine and Pediatrics University of Pittsburgh School of Medicine Some definitions
More informationPulmonary circulation. Lung Blood supply : lungs have a unique blood supply system :
Dr. Ali Naji Pulmonary circulation Lung Blood supply : lungs have a unique blood supply system : 1. Pulmonary circulation 2. Bronchial circulation 1- Pulmonary circulation : receives the whole cardiac
More informationJune 2011 Bill Streett-Training Section Chief
Capnography 102 June 2011 Bill Streett-Training Section Chief Terminology Capnography: the measurement and numerical display of end-tidal CO2 concentration, at the patient s airway, during a respiratory
More informationProvide guidelines for the management of mechanical ventilation in infants <34 weeks gestation.
Page 1 of 5 PURPOSE: Provide guidelines for the management of mechanical ventilation in infants
More informationRespiratory Failure. Causes of Acute Respiratory Failure (ARF): a- Intrapulmonary:
Respiratory failure exists whenever the exchange of O 2 for CO 2 in the lungs cannot keep up with the rate of O 2 consumption & CO 2 production in the cells of the body. This results in a fall in arterial
More informationECMO FOR PEDIATRIC RESPIRATORY FAILURE. Novik Budiwardhana * PCICU Harapan Kita National Cardiovascular Center Jakarta
ECMO FOR PEDIATRIC RESPIRATORY FAILURE Novik Budiwardhana * PCICU Harapan Kita National Cardiovascular Center Jakarta Introduction Case D 8 month old baby with severe ARDS with fungal sepsis. He was on
More informationProne Position in ARDS
Prone Position in ARDS Rich Kallet MS RRT FAARC, FCCM Respiratory Care Services San Francisco General Hospital University of California, San Francisco, Case Study A 39 yo F admitted to SFGH TICU s/p hanging,
More informationWet Lungs Dry lungs Impact on Outcome in ARDS. Charlie Phillips MD Division of PCCM OHSU 2009
Wet Lungs Dry lungs Impact on Outcome in ARDS Charlie Phillips MD Division of PCCM OHSU 2009 Today s talk Pathophysiology of ARDS The case for dry Targeting EVLW Disclosures Advisor for Pulsion Medical
More informationCollaborative Project of the 7th Framework Programme. WP6: Tools for bio-researchers and clinicians
G.A. nº 270086 Collaborative Project of the 7th Framework Programme WP6: Tools for bio-researchers and clinicians Deliverable 6.1: Design of Inference Engine v.1.0 31/10/2011 www.synergy-copd.eu Document
More informationAcute Respiratory Failure
Acute Respiratory Failure יובל לאונוב ? Respiratory failure? Respiratory a o y failure Hypoxic Hypercapnic Hypoxemic Respiratory Failure (type I) Hypercapnic Respiratory Failure (type II) Hypercapnic Respiratory
More informationManagement of refractory ARDS. Saurabh maji
Management of refractory ARDS Saurabh maji Refractory hypoxemia as PaO2/FIO2 is less than 100 mm Hg, inability to keep plateau pressure below 30 cm H2O despite a VT of 4 ml/kg development of barotrauma
More informationRESPIRATORY FAILURE. Dr Graeme McCauley KGH
RESPIRATORY FAILURE Dr Graeme McCauley KGH Definitions Failure to oxygenate-pao2 < 60 Failure to clear CO2-PaCO2 > 50 Acute vs Chronic Hypoxemic failure- type l Hypercapneic failure- type ll Causes of
More informationDon t let your patients turn blue! Isn t it about time you used etco 2?
Don t let your patients turn blue! Isn t it about time you used etco 2? American Association of Critical Care Nurses National Teaching Institute Expo Ed 2013 Susan Thibeault MS, CRNA, APRN, CCRN, EMT-P
More informationCase discussion Acute severe asthma during pregnancy. J.G. van der Hoeven
Case discussion Acute severe asthma during pregnancy J.G. van der Hoeven Case (1) 32-year-old female - gravida 3 - para 2 Previous medical history - asthma Pregnant (33 w) Acute onset fever with wheezing
More informationTHE ACUTE RESPIRATORY DISTRESS SYNDROME. Daniel Brockman, DO
THE ACUTE RESPIRATORY DISTRESS SYNDROME Daniel Brockman, DO Objectives Describe the history and evolution of the diagnosis of ARDS Review the diagnostic criteria for ARDS Discuss the primary interventions
More informationBiPAPS/TVAPSCPAPASV???? Lori Davis, B.Sc., R.C.P.T.(P), RPSGT
BiPAPS/TVAPSCPAPASV???? Lori Davis, B.Sc., R.C.P.T.(P), RPSGT Modes Continuous Positive Airway Pressure (CPAP): One set pressure which is the same on inspiration and expiration Auto-PAP (APAP) - Provides
More informationبسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Yesterday we spoke of the increased airway resistance and its two examples: 1) emphysema, where we have destruction of the alveolar wall and thus reducing the area available for
More informationChapter 38: Pulmonary Circulation, Pulmonary Edema, Pleural Fluid UNIT VII. Slides by Robert L. Hester, PhD
UNIT VII Chapter 38: Pulmonary Circulation, Pulmonary Edema, Pleural Fluid Slides by Robert L. Hester, PhD Objectives Describe the pulmonary circulation Describe the pulmonary blood pressures List the
More informationPerformance Enhancement. Cardiovascular/Respiratory Systems and Athletic Performance
Performance Enhancement Cardiovascular/Respiratory Systems and Athletic Performance Functions of the Cardiovascular System Deliver oxygen & nutrients to body tissues Carry wastes from the cells Anatomy
More informationARDS Assisted ventilation and prone position. ICU Fellowship Training Radboudumc
ARDS Assisted ventilation and prone position ICU Fellowship Training Radboudumc Fig. 1 Physiological mechanisms controlling respiratory drive and clinical consequences of inappropriate respiratory drive
More informationNon-invasive Positive Pressure Mechanical Ventilation: NIPPV: CPAP BPAP IPAP EPAP. My Real Goals. What s new in 2018? OMG PAP?
Non-invasive Positive Pressure Mechanical Ventilation: What s new in 2018? Geoffrey R. Connors, MD, FACP Associate Professor of Medicine University of Colorado School of Medicine Division of Pulmonary
More informationa. Describe the physiological consequences of intermittent positive pressure ventilation and positive end-expiratory pressure.
B. 10 Applied Respiratory Physiology a. Describe the physiological consequences of intermittent positive pressure ventilation and positive end-expiratory pressure. Intermittent positive pressure ventilation
More informationVariation in lung with normal, quiet breathing. Minimal lung volume (residual volume) at maximum deflation. Total lung capacity at maximum inflation
r Total lung capacity at maximum inflation Variation in lung with normal, quiet breathing Volume of lungs at end of normal inspiration (average 2,200 ml) Minimal lung volume (residual volume) at maximum
More informationDisclosures. Learning Objectives. Mechanical Ventilation of Infants with Severe BPD: An Interdisciplinary Approach 3/10/2017
Mechanical Ventilation of Infants with Severe BPD: An Interdisciplinary Approach Steven H. Abman, MD Professor, Department of Pediatrics Director, Pediatric Heart Lung Center University of Colorado School
More informationMECHANICAL VENTILATION PROTOCOLS
GENERAL or SURGICAL Initial Ventilator Parameters Ventilator Management (see appendix I) Assess Patient Data (see appendix II) Data Collection Mode: Tidal Volume: FIO2: PEEP: Rate: I:E Ratio: ACUTE PHASE
More informationWeaning from Mechanical Ventilation. Dr Azmin Huda Abdul Rahim
Weaning from Mechanical Ventilation Dr Azmin Huda Abdul Rahim Content Definition Classification Weaning criteria Weaning methods Criteria for extubation Introduction Weaning comprises 40% of the duration
More informationLung Recruitment Strategies in Anesthesia
Lung Recruitment Strategies in Anesthesia Intraoperative ventilatory management to prevent Post-operative Pulmonary Complications Kook-Hyun Lee, MD, PhD Department of Anesthesiology Seoul National University
More informationAVOIDING THE CRASH 3: RELAX, OPTIMAL POST-AIRWAY MANAGEMENT AVOIDING THE CRASH: OPTIMIZE YOUR PRE, PERI, AND POST AIRWAY MANAGEMENT
AVOIDING THE CRASH: OPTIMIZE YOUR PRE, PERI, AND POST AIRWAY MANAGEMENT Robert J. Vissers MD Chief, Emergency Medicine, Quality Chair, Legacy Emanuel Medical Center Adjunct Associate Professor, OHSU Portland,
More informationRecent Advances in Respiratory Medicine
Recent Advances in Respiratory Medicine Dr. R KUMAR Pulmonologist Non Invasive Ventilation (NIV) NIV Noninvasive ventilation (NIV) refers to the administration of ventilatory support without using an invasive
More informationNON-INVASIVE VENTILATION. Lijun Ding 23 Jan 2018
NON-INVASIVE VENTILATION Lijun Ding 23 Jan 2018 Learning objectives What is NIV The difference between CPAP and BiPAP The indication of the use of NIV Complication of NIV application Patient monitoring
More informationEmergency Medicine High Velocity Nasal Insufflation (Hi-VNI) VAPOTHERM POCKET GUIDE
Emergency Medicine High Velocity Nasal Insufflation (Hi-VNI) VAPOTHERM POCKET GUIDE Indications for Vapotherm High Velocity Nasal Insufflation (Hi-VNI ) administration, the patient should be: Spontaneously
More informationVentilator Waveforms: Interpretation
Ventilator Waveforms: Interpretation Albert L. Rafanan, MD, FPCCP Pulmonary, Critical Care and Sleep Medicine Chong Hua Hospital, Cebu City Types of Waveforms Scalars are waveform representations of pressure,
More informationNIV use in ED. Dr. Khalfan AL Amrani Emergency Resuscitation Symposium 2 nd May 2016 SQUH
NIV use in ED Dr. Khalfan AL Amrani Emergency Resuscitation Symposium 2 nd May 2016 SQUH Outline History & Introduction Overview of NIV application Review of proven uses of NIV History of Ventilation 1940
More informationC h a p t e r 1 4 Ventilator Support
C h a p t e r 1 4 Ventilator Support Shirish Prayag Ex. Hon. Asst. Prof of Medicine, BJ Medical College and Sassoon Hospital, Pune; Chief Consultant in Internal Medicine and Critical Care, Shree Medical
More informationAPPENDIX VI HFOV Quick Guide
APPENDIX VI HFOV Quick Guide Overall goal: Maintain PH in the target range at the minimum tidal volume. This is achieved by favoring higher frequencies over lower P (amplitude). This goal is also promoted
More informationARDS and Lung Protection
ARDS and Lung Protection Kristina Sullivan, MD Associate Professor University of California, San Francisco Department of Anesthesia and Perioperative Care Division of Critical Care Medicine Overview Low
More informationWeeks 1-3:Cardiovascular
Weeks 1-3:Cardiovascular Cardiac Output The total volume of blood ejected from the ventricles in one minute is known as the cardiac output. Heart Rate (HR) X Stroke Volume (SV) = Cardiac Output Normal
More informationWhat s New About Proning?
1 What s New About Proning? J. Brady Scott, MSc, RRT-ACCS, AE-C, FAARC Director of Clinical Education and Assistant Professor Department of Cardiopulmonary Sciences Division of Respiratory Care Rush University
More informationKinetics and Monitoring of Inhaled Anesthetics. Copyright , James H Philip, all rights reserved
Kinetics and Monitoring of Inhaled Anesthetics Copyright 1980-2014, James H Philip, all rights reserved Ready Kinetics and Monitoring of Inhaled Anesthetics James H. Philip, M.E.(E.), M.D. Anesthesiologist
More informationEmphysema. Lungs The lungs help us breathe in oxygen and breathe out carbon dioxide. Everyone is born with 2 lungs: a right lung and a left lung.
Emphysema Introduction Emphysema is a type of chronic obstructive pulmonary disease, or COPD. COPD affects millions of people worldwide. Emphysema involves damage to the air sacs in the lungs. This makes
More information11 th Annual Congress Turkish Thoracic Society. Mechanical Ventilation in Acute Hypoxemic Respiratory Failure
11 th Annual Congress Turkish Thoracic Society Mechanical Ventilation in Acute Hypoxemic Respiratory Failure Lluis Blanch MD PhD Senior Critical Care Center Scientific Director Corporació Parc Taulí Universitat
More informationInterfacility Protocol Protocol Title:
Interfacility Protocol Protocol Title: Mechanical Ventilator Monitoring & Management Original Adoption Date: 05/2009 Past Protocol Updates 05/2009, 12/2013 Date of Most Recent Update: March 23, 2015 Medical
More informationECMO for Severe Hypoxemic Respiratory Failure: Pro-Con Debate. Carolyn Calfee, MD MAS Mark Eisner, MD MPH
ECMO for Severe Hypoxemic Respiratory Failure: Pro-Con Debate Carolyn Calfee, MD MAS Mark Eisner, MD MPH June 3, 2010 Case Presentation Setting: Community hospital, November 2009 29 year old woman with
More informationGroup B: Directed self-study Group C: Anatomy lab. Lecture: Structure and function of larynx. Lecture: Dead space & compliance of lungs
Timetable Week 1 (1 st January 2018) Theme: Structure and functions of the lungs Group A: Anatomy lab Group C: Histology lab Upper Group B: Anatomy lab Group C: Anatomy lab Group A: Histology lab Upper
More informationPaediatric Pulmonary Arterial Hypertension (PAH)
Paediatric Pulmonary Arterial Hypertension (PAH) Regulators perspective on a Global challenge EMA FDA HC paediatric PAH workshop 12 th June 2017 Cécile Ollivier European Medicines Agency Science and Innovation
More informationOxygen Toxicity Walid Habre, MD, PhD
Oxygen Toxicity Walid Habre, MD, PhD Anaesthesiological Investigations Unit & Paediatric Anaesthesia Unit Geneva University Hospitals and University of Geneva www.walidhabre.org Disclosure I have no conflicts
More informationHepatopulmonary Syndrome: An Update
Hepatopulmonary Syndrome: An Update Michael J. Krowka MD Professor of Medicine Division of Pulmonary and Critical Care Division of Gastroenterology and Hepatology Mayo Clinic Falk Liver Week October 11,
More informationBronchoalveolar lavage (BAL) with surfactant in pediatric ARDS
Bronchoalveolar lavage (BAL) with surfactant in pediatric ARDS M. Luchetti, E. M. Galassini, A. Galbiati, C. Pagani,, F. Silla and G. A. Marraro gmarraro@picu.it www.picu.it Anesthesia and Intensive Care
More information